David H McDermott, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David H McDermott, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:49 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05078879 · Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 DeficiencyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Crohn's Disease, Glycogen Metabolism, Inflammatory Bowel Disease (IBD) · principal investigator
- Ph2/Ph3NCT02231879 · Plerixafor Versus G-CSF in the Treatment of People With WHIM SyndromeNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Myelokathexis, Infections, Neutropenia · principal investigator
- Ph1/Ph2NCT00967785 · A Phase I Study of Mozobil in the Treatment of Patients With WHIMSNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Leukopenia, Neutropenia, Infections · principal investigator
- N/ANCT00359307 · Genetic Factors in AtherosclerosisNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Atherosclerosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.